SScience Read More Nasal Spray Reverses Brain Aging and InflammationApril 15, 2026 Summary: For decades, “neuroinflammaging”, the slow-burning inflammation that causes brain fog and memory decline, was considered an unavoidable part…
MMedication Read More Milestone announces acceptance of MAA by EMA for etripamil nasal sprayJanuary 7, 2026 Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA,…
MMedication Read More Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)December 19, 2025 Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
MMedication Read More Milestone Pharma gets FDA approval for first PSVT nasal sprayDecember 15, 2025 Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…
MMedication Read More Walgreens recalls nasal spray over possible contaminationNovember 28, 2025 (CNN) – Walgreens is recalling more than 41,000 bottles of nasal spray because they may be contaminated with…
MMedication Read More Walgreens recalls nasal spray over possible contaminationNovember 28, 2025 (CNN) – Walgreens is recalling more than 41,000 bottles of nasal spray because they may be contaminated with…